secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xtant Medical Holdings, Inc. (XTNT)
CIK:        0001453593
Form:       8-K
Filed at:   2023-06-20T23:59:59+00:00
Accession:  0001493152-23-021783
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Xtant Medical enters $5M asset purchase agreement for Surgalign assets as stalking-horse bidder
--------------------------------------------------------------------------------

- Purchase price $5M cash; 10% ($0.5M) in escrow; break-up fee of 3% if outbid.
- Seller Surgalign filed Chapter 11 on June 19, 2023; sale under Bankruptcy Code Section 363.
- Acquired assets include inventory, IP, contracts, equipment, and equity of international subsidiaries.
- Transaction requires Bankruptcy Court approval and subject to auction with potential competing bids.
- Xtant designated as stalking horse bidder; deal expected to close by September 1, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1453593/000149315223021783/0001493152-23-021783-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1453593/000149315223021783/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-021783

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer